Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New use of ciclosporin recommended for approval

Feb. 5, 1997

IL-6 antagonists from Daicel

Feb. 5, 1997

Dimethaid files second NDA for topical NSAID

Jan. 30, 1997

Dual COX-2/5-LO inhibitors reported by Searle

Jan. 29, 1997

Allelix develops antiinflammatory peptides

Jan. 29, 1997

COX-2 inhibitors reported by Merck Frosst

Jan. 28, 1997

Merck Frosst discovers orally active COX-2 inhibitors

Jan. 24, 1997

MMP inhibitors disclosed by Fuji Yakuhin

Jan. 24, 1997

Eisai discloses IL-1 inhibitors

Jan. 23, 1997

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...